IncFact
Company Profiles: Revenue, Growth, Competition

In-Vitro Diagnostic Substance Manufacturing Industry

NAICS: 325413

For additional companies see the Pharmaceutical & Medicine Manufacturing Industry

Contents

.In-Vitro Diagnostic Substance Manufacturing Market Share: Largest Companies in the In-Vitro Diagnostic Substance Manufacturing Industry

Company HeadquartersRevenue ($ MM)
AVIOQResearch Triangle Park, NC100 
EXPRESS DIAGNOSTIC INT'LBlue Earth, MN86 
LEE BIOSOLUTIONSMaryland Heights, MO85 
UTAK LABORATORIESValencia, CA54 
RANDOX LABORATORIES-USKearneysville, WV49 
ATLAS BIOLOGICALSFort Collins, CO21 
APOLLO MEDICAL DEVICESCleveland, OH9 
SYMPANOPortland, OR6 


See exact company revenues in this list


This is a list of the largest companies active in the In-Vitro Diagnostic Substance Manufacturing industry. This differs from market share in the following example: One business with revenues of $100 million generates 10% of its business from the In-Vitro Diagnostic Substance Manufacturing industry. A second firm, with revenues of $20 million, generates all of its business from this industry. In our list, we show the businesses having revenues of $100 million and $20 million, respectively. However, the market share would compare the $10 million in industry-specific revenue to the $20 million: the second company has twice the market share even though it is "smaller" in size.


.Additional Companies Operating in the In-Vitro Diagnostic Substance Manufacturing Industry

Company HeadquartersRevenue ($ MM)
ABBOTT LABORATORIES (NYSE: ABT)Abbott Park, IL100 
IMMUCORNorcross, GA4 
BIOMEDICAL RESEARCH FOUNDATION OF NORTHWEST LOUISIANAShreveport, LA3 
GEN-PROBESan Diego, CA2 
BIO-RAD LABORATORIES (NYSE: BIO)Hercules, CA2 
DIASORINStillwater, MN2 
CELL SIGNALING TECHNOLOGYDanvers, MA2 
CEPHEID (NASDAQ: CPHD)Sunnyvale, CA2 




.Growth: Fastest Growing In-Vitro Diagnostic Substance Manufacturing Companies

A list of competitors in the In-Vitro Diagnostic Substance Manufacturing industry that are rapidly expanding. Businesses may grow organically or through acquisition. Typically, small or midsized companies are in "growth" mode and can expand more rapidly. However, large businesses may have the strategy and financial capabilities to scale rapidly. Businesses that employ a "roll-up" strategy make multiple acquisitions of smaller businesses to form a single large corporation that controls a greater market share than its competitors and benefits from economies of scale.

View List


. Latest In-Vitro Diagnostic Substance Manufacturing Trademark Applications

Trademark applications show the direction a company's marketing strategy is headed. Trademarks may include brand names, product names, logos, and slogans. This list identifies companies that are investing in new products or developing new marketing strategies.

Company TrademarkApplication Date
Calbiotech NEXUS
Medical Diagnostic instruments, namely, automated immunoassay analyzers for in vitro diagnosis
06/10/2019
Mammoth Biosciences MAMMOTH
CRISPR inhibitors for scientific and research purposes; CRISPR controls for scientific and research purposes; CRISPR reagents for editing genomes for scientific and research purposes
04/04/2019
Mcwilliams BALANCE BLOCKING BUFFER
Diagnostic reagents for scientific, medical, clinical, research and manufacturing use
03/19/2019
Clarity Diagnostics CLARITY
02/28/2019


View Full List


.Small Business Financing

Small businesses that have received financing may expand soon. Financing may be required for capital-intensive investments, such as real estate or equipment purchases. In-Vitro Diagnostic Substance Manufacturing businesses may use the financing to cover startup expenses or the costs of hiring new employees. Loans differ from equity investments in the level of risk that is expected: loans frequently have collateral either directly or implicitly through the business or the owners that ensure repayment. Equity investment has the possibility for much greater returns, but offers no guarantee the principle will be repayed. Convertible securities combine the two concepts, but is used by private-equity firms rather than main street startups.

View List


. Venture Funding

These In-Vitro Diagnostic Substance Manufacturing companies are actively raising capital from venture capital firms, private equity, or other investors. Businesses with venture funding generally have higher growth prospects, either through bringing new concepts to market, using innovative business practices, or savvy management.

View List